e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Garcia-Vidal C., Fernandez-Sabe N., Carratala J., Diaz V., Verdaguer R., Dorca J., Manresa F., Gudiol F.
Source:
Eur Respir J 2008; 32: 733-739
Journal Issue:
September
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Garcia-Vidal C., Fernandez-Sabe N., Carratala J., Diaz V., Verdaguer R., Dorca J., Manresa F., Gudiol F.. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008; 32: 733-739
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Community-acquired pneumonia due to
streptococcus pneumoniae
in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including
Streptococcus pneumoniae
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Source: Eur Respir J 2006; 27: 1010-1019
Year: 2006
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Source: Eur Respir J 2008; 31: 625-632
Year: 2008
Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Aetiopathogenesis of VAP revisited
Source: Eur Respir Mon 2011; 53: 1-10
Year: 2011
Factors associated with hospital mortality in community-acquired legionellosis in France
Source: Eur Respir J 2012; 39: 963-970
Year: 2012
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009
Community-acquired pneumonia in the elderly
Source: Eur Respir Mon; 2009: 43: 111–132
Year: 2009
Community-acquired pneumonia in younger patients is an entity on its own
Source: Eur Respir J 2012; 39: 1156-1161
Year: 2012
MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009
S. pneumoniae
community-acquired pneumonia (SP-CAP): relationship between mortality and antibiotic susceptibility and risk factors for drug resistance
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept